Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Other(6)
Área temáticas
Enfermedades(6)
Farmacología y terapéutica(3)
Cirugía y especialidades médicas afines(2)
Medicina y salud(2)
Fisiología humana(1)
Origen
google(6)
COMPASSIONATE USE PROGRAM (CUP) WITH RUXOLITINIB IN PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF), AND POST-ESSENTIAL THROMBOCYTHEMIA …
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:googleIBRUTINIB-RELATED TOXICITY AND SUSPENSION OF TREATMENT
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:googlePOLYGLOBULIA IN THE YOUNG MAN IN THE AGE OF HEALTH CONTROLS: NEED FOR NEW PHYSIOLOGICAL RANGES OR EXCEPTION TO THE WHO 2016 CLASSIFICATION?
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:googleMOLECULAR STUDY OF 11Q23 REARRANGEMENTS/MLL IN A COHORT OF ACUTE MYELOID LEUKEMIAS (AML) DURING 12 YEARS
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:googleSAFETY PROFILE OF RUXOLITINIB IN PRIMARY MYELOFIBROSIS, POST-POLYCITEMIA VERA MYELOFIBROSIS AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN A COMPASSIONATE USE PROGRAM (CUP …
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:googleTHE BIGGEST MOLECULAR ANSWER IN THE IRIS STUDY: A REFLECTION FROM A GROUP OF PATIENTS SUBIDEAL RESPONDING WITH LEUKEMIA CHRONIC MIELOIDE (LMC) FOR MORE THAN 5 YEARS OF MONITORING
OtherAbstract:Palabras claves:Autores:Olga Gloria Barbón-PérezFuentes:google